Browse All

Current Filters

CLEAR FILTER x

TITLE

e086 Assessing Representativeness and Outcomes of Medicare vs. Other Insurance Groups in THA: Implications for CMS' Upcoming Mandatory PROMs Reporting Policy

e090 Developmental Dysplasia of the Hip: An Independent Risk Factor for Adverse Outcomes Following Total Hip Arthroplasty

e097 Trends, Demographics, and Outcomes for Glucagon-Like Peptide-1 Agonist Use in Total Hip Arthroplasty: An 11-Year Perspective

e101 Native Femoral Version Among Primary Total Hip Arthroplasty Patients: Implications for Implant Placement

e102 Increased risk of flexion impingement and posterior instability following Total Hip Arthroplasty